Pnc Financial Services Group, Inc. Arcellx, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Arcellx, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 291 shares of ACLX stock, worth $18,047. This represents 0.0% of its overall portfolio holdings.
Number of Shares
291
Previous 45
546.67%
Holding current value
$18,047
Previous $3,000
633.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ACLX
# of Institutions
224Shares Held
44.7MCall Options Held
434KPut Options Held
433K-
Paradigm Biocapital Advisors LP New York, NY4.37MShares$271 Million12.7% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$232 Million20.37% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$218 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.48MShares$216 Million8.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$207 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $2.72B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...